For many people, Lambaréné is known through the writings of Albert Schweitzer, who introduced the town to the world through his reflections on life at the edge of the ...
RareDx for Pediatricians provides information to support the recognition and evaluation of rare diseases in children. It is intended for pediatricians, family medicine clinicians, nurse practitioners, and other primary care ...
The University of Oxford welcomed international partners for the GLOW-CAT International Workshop, held from 11–13 March 2026 at the new Life and Mind Building, home to the Department of Experimental ...
The Global Health Network is delighted to share a new BMJ opinion piece arguing that data sharing must evolve towards data sovereignty. This is the ‘why’ as a precursor ...
Developed following the 2014 to 2015 West Africa Ebola outbreak and funded by the Department of Health and Social Care’s Official Development Assistance (ODA) budget, UK-PHRST works with low- and middle-income countries to ...
CEPI has developed a guidance document defining key Phase 1 elements to harmonize safety and immunogenicity assessment, enable comparability across candidates, support dose selection, and accelerate progression to Phase 2/3 during outbreaks, while ensuring ICH-GCP compliance. Read more
CEPI is seeking technical partners to enable rapid, ethical, and coordinated access to high-quality biospecimens during outbreaks and public health emergencies. Organisations of all sizes and capability levels are encouraged to apply, particularly those located in low- and middle-income countries. Read more
CEPI has announced a funding opportunity to develop innovative analytical technologies for vaccines. The goal is to reduce vaccine development, manufacturing, and release times; lower costs, improve equitable deployment in Low to Middle-Income Countries, and enhance analytical insights for vaccines. Read more
Proposed projects will be expected to increase regulatory and research ethics oversight capacity of national and regional authorities in SSA to operate at WHO maturity level 3 for clinical trial, registration and/or PV for medical products (therapeutics/vaccines) Read more
CEPI has published its first Biosecurity Policy, strengthening safe, responsible, and equitable research. The Policy outlines clear biosecurity and biosafety requirements for Third Parties, supporting our mission to advance global health preparedness and protect communities through secure scientific innovation. Read more
The BSI will help facilitate the timely and ethical collection of biological samples in an outbreak. The BSI aims to make biospecimens available to develop assays and standards within weeks, rather than the six months it typically takes today. Read more
Resources
In collaboration with TGHN, CEPI created this playbook to bring together the many tools, resources and materials generated for pandemic preparedness and response from the COVID-19 pandemic. The first (Regulatory) chapter is now available.
TRANSVAC Academy offers training modules in vaccine R&D including grant management, statistics, cytometry and advanced process development. CEPI funded scholarships are provided to selected applicants from LMICs.
SPEAC is a CEPI and Brighton Collaboration project. SPEAC provides vaccine safety tools, resources, and expertise throughout the vaccine development process to enhance safety and build confidence in vaccines.
Monitoring Vaccine Performance against SARS CoV-2 Variants
The IVAC COVID-19 Vaccine Effectiveness Project (a CEPI- funded global systematic review which also includes neutralization capacity) outputs are publicly available on VIEWhub to assist all policy makers
International Pandemic Preparedness Secretariat
The IPPS serves to join up relevant states, the private sector, and global health institutions in support of the 100 Days Mission, across vaccines, therapeutics, and diagnostics. It performs a global annual progress review related to the 100 DM which feeds into implementation reports.
Vaccine Development
Process Maps
The UK Vaccine R&D Network has developed vaccine development maps to show key stages in human and veterinary vaccines development up to Phase III clinical trials. These process maps and associated case studies provide support in understanding key stages in vaccine development and where bottlenecks could cause delays.
